Minerva Neurosciences Stock Performance
| NERV Stock | USD 6.27 0.02 0.32% |
On a scale of 0 to 100, Minerva Neurosciences holds a performance score of 10. The company secures a Beta (Market Risk) of 1.31, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Minerva Neurosciences will likely underperform. Please check Minerva Neurosciences' value at risk, as well as the relationship between the kurtosis and price action indicator , to make a quick decision on whether Minerva Neurosciences' current price movements will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Minerva Neurosciences are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Minerva Neurosciences showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (0.32) | Five Day Return 46.15 | Year To Date Return 59.95 | Ten Year Return (83.87) | All Time Return (87.05) |
Last Split Factor 1:8 | Last Split Date 2022-06-21 |
1 | Minerva appoints Kaul to board of directors NERV | 11/19/2025 |
2 | ProMIS Neurosciences Announces New Peer-Reviewed Publication Highlighting Selective Targeting of Toxic Oligomers for Potential Clinical Benefit and Reduced ARIA... | 12/10/2025 |
3 | ProMIS Neurosciences Exceeds Target Enrollment in PRECISE-AD Phase 1b Clinical Trial of PMN310 in Alzheimers Disease | 12/18/2025 |
4 | Acquisition by Remy Luthringer of 2250000 shares of Minerva Neurosciences at 3.98 subject to Rule 16b-3 | 12/22/2025 |
5 | Minerva Neurosciences Upgraded to Hold at Wall Street Zen - MarketBeat | 01/02/2026 |
6 | Wall Street Recap Why analysts upgrade Minerva Neurosciences Inc. stock - 2025 Key Highlights Verified Short-Term Trading Plans - moha.gov.vn | 01/13/2026 |
7 | Acquisition by Laghrissi-thode Fouzia of 2500 shares of Minerva Neurosciences at 3.32 subject to Rule 16b-3 | 01/15/2026 |
8 | Minerva Neurosciences Share Price Passes Above 50 Day Moving Average - Whats Next - MarketBeat | 01/20/2026 |
9 | Minerva Neurosciences Share Price Passes Above 50-Day Moving Average - Time to Sell - MarketBeat | 01/28/2026 |
10 | Minerva Neurosciences Spotlights Roluperidone, Lays Out Confirmatory Phase 3 Timeline for Schizophrenia | 02/04/2026 |
11 | Minerva Neurosciences Stock Price Passes Above 50-Day Moving Average - Whats Next - MarketBeat | 02/12/2026 |
Minerva Neurosciences Relative Risk vs. Return Landscape
If you would invest 436.00 in Minerva Neurosciences on November 16, 2025 and sell it today you would earn a total of 191.00 from holding Minerva Neurosciences or generate 43.81% return on investment over 90 days. Minerva Neurosciences is currently generating 0.7758% in daily expected returns and assumes 6.083% risk (volatility on return distribution) over the 90 days horizon. In different words, 54% of stocks are less volatile than Minerva, and 85% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Minerva Neurosciences Target Price Odds to finish over Current Price
The tendency of Minerva Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 6.27 | 90 days | 6.27 | near 1 |
Based on a normal probability distribution, the odds of Minerva Neurosciences to move above the current price in 90 days from now is near 1 (This Minerva Neurosciences probability density function shows the probability of Minerva Stock to fall within a particular range of prices over 90 days) .
Minerva Neurosciences Price Density |
| Price |
Predictive Modules for Minerva Neurosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Minerva Neurosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Minerva Neurosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Minerva Neurosciences is not an exception. The market had few large corrections towards the Minerva Neurosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Minerva Neurosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Minerva Neurosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.84 | |
β | Beta against Dow Jones | 1.31 | |
σ | Overall volatility | 0.63 | |
Ir | Information ratio | 0.14 |
Minerva Neurosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Minerva Neurosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Minerva Neurosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Minerva Neurosciences is way too risky over 90 days horizon | |
| Minerva Neurosciences appears to be risky and price may revert if volatility continues | |
| Minerva Neurosciences has high likelihood to experience some financial distress in the next 2 years | |
| Minerva Neurosciences currently holds about 40.22 M in cash with (19.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.53, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 22.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Minerva Neurosciences Stock Price Passes Above 50-Day Moving Average - Whats Next - MarketBeat |
Minerva Neurosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Minerva Stock often depends not only on the future outlook of the current and potential Minerva Neurosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Minerva Neurosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 7.6 M | |
| Cash And Short Term Investments | 21.4 M |
Minerva Neurosciences Fundamentals Growth
Minerva Stock prices reflect investors' perceptions of the future prospects and financial health of Minerva Neurosciences, and Minerva Neurosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Minerva Stock performance.
| Return On Equity | -6.75 | ||||
| Return On Asset | -0.26 | ||||
| Current Valuation | 259.48 M | ||||
| Shares Outstanding | 6.99 M | ||||
| Price To Earning | 69.58 X | ||||
| Price To Book | 2.68 X | ||||
| Price To Sales | 1.87 X | ||||
| Gross Profit | (5.57 M) | ||||
| EBITDA | 6.02 M | ||||
| Net Income | 1.44 M | ||||
| Cash And Equivalents | 40.22 M | ||||
| Cash Per Share | 7.53 X | ||||
| Total Debt | 60 M | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 20.41 X | ||||
| Book Value Per Share | (4.95) X | ||||
| Cash Flow From Operations | (19.55 M) | ||||
| Earnings Per Share | (1.85) X | ||||
| Market Capitalization | 26.92 M | ||||
| Total Asset | 37.14 M | ||||
| Retained Earnings | (395.38 M) | ||||
| Working Capital | 19.43 M | ||||
| Current Asset | 33.48 M | ||||
| Current Liabilities | 5.32 M | ||||
About Minerva Neurosciences Performance
Evaluating Minerva Neurosciences' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Minerva Neurosciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Minerva Neurosciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.06 | 0.06 | |
| Return On Capital Employed | (0.57) | (0.60) | |
| Return On Assets | 0.03 | 0.04 | |
| Return On Equity | (0.05) | (0.05) |
Things to note about Minerva Neurosciences performance evaluation
Checking the ongoing alerts about Minerva Neurosciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Minerva Neurosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Minerva Neurosciences is way too risky over 90 days horizon | |
| Minerva Neurosciences appears to be risky and price may revert if volatility continues | |
| Minerva Neurosciences has high likelihood to experience some financial distress in the next 2 years | |
| Minerva Neurosciences currently holds about 40.22 M in cash with (19.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.53, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 22.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Minerva Neurosciences Stock Price Passes Above 50-Day Moving Average - Whats Next - MarketBeat |
- Analyzing Minerva Neurosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Minerva Neurosciences' stock is overvalued or undervalued compared to its peers.
- Examining Minerva Neurosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Minerva Neurosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Minerva Neurosciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Minerva Neurosciences' stock. These opinions can provide insight into Minerva Neurosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Minerva Stock Analysis
When running Minerva Neurosciences' price analysis, check to measure Minerva Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Neurosciences is operating at the current time. Most of Minerva Neurosciences' value examination focuses on studying past and present price action to predict the probability of Minerva Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Neurosciences' price. Additionally, you may evaluate how the addition of Minerva Neurosciences to your portfolios can decrease your overall portfolio volatility.